What is the typical dose and usage of injectable Ranitidine (Rantac)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Injectable Ranitidine (Rantac) Dosing and Administration

The standard intramuscular (IM) dose of ranitidine is 50 mg every 6 to 8 hours for adults, with no dilution necessary. 1

Adult Dosing

  • For adults, the recommended IM dose is 50 mg per dose, administered every 6 to 8 hours 1
  • For intravenous (IV) administration, ranitidine can be given as:
    • Intermittent bolus: 50 mg every 6 to 8 hours, diluted to a concentration no greater than 2.5 mg/mL and injected at a rate no greater than 4 mL/min 1
    • Intermittent infusion: 50 mg every 6 to 8 hours, diluted to a concentration no greater than 0.5 mg/mL and infused over 15-20 minutes 1
    • Continuous IV infusion: 6.25 mg/hour (150 mg in 250 mL of compatible solution at 10.7 mL/hour) 1

Pediatric Dosing

  • For children, the recommended total daily dose is 2 to 4 mg/kg, divided and administered every 6 to 8 hours 1
  • The maximum single dose should not exceed 50 mg, even in larger children 2
  • For specific conditions like anaphylaxis management, the pediatric IM dose is 1 mg/kg per dose, with a dosing range of 12.5 to 50 mg 2

Special Populations

  • For patients with impaired renal function (creatinine clearance <50 mL/min), the recommended dose is 50 mg every 18 to 24 hours 1
  • If clinically necessary, the frequency may be increased to every 12 hours with caution 1
  • For hemodialysis patients, dosing should ideally be scheduled to coincide with the end of hemodialysis 1
  • Elderly patients may require dose adjustments due to decreased renal function 1

Administration Technique

  • For IM injections, administer in the gluteal region, specifically in the posterior lateral aspect of the upper buttocks to avoid major nerves and blood vessels 3
  • Use the upper outer quadrant of the buttock to avoid sciatic nerve injury 3

Higher Dose Requirements

  • In some patients with pathological hypersecretory conditions (like Zollinger-Ellison syndrome), higher doses may be necessary 1
  • For Zollinger-Ellison patients, continuous IV infusion can be started at 1.0 mg/kg/hour and adjusted upward in 0.5 mg/kg/hour increments based on gastric acid output measurements 1
  • Dosages up to 2.5 mg/kg/hour and infusion rates as high as 220 mg/hour have been used in these cases 1

Efficacy Considerations

  • Studies have shown that continuous IV infusion tends to maintain more consistent intragastric pH control compared to bolus injections 4, 5
  • Continuous infusion of ranitidine maintained pH above 4 for 52% of the time compared to 40% with repeated boluses in one study 5

Safety Profile

  • Ranitidine has demonstrated an excellent safety profile with adverse event rates similar to placebo in clinical trials 6
  • No evidence of dose-related toxicity has been observed across an eightfold range of therapeutic doses 6

References

Guideline

Intramuscular Ranitidine Dosing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Intramuscular Administration of Ranitidine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The safety of ranitidine in over a decade of use.

Alimentary pharmacology & therapeutics, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.